Global Oligonucleotide Synthesis Market, By Product (Oligonucleotide, Reagents, and Equipment), Type (Custom Oligos and Predesigned Oligos), Application (Therapeutic Applications, Diagnostics, Research, and Others), End User (Academic Research Institutes, Pharmaceutical and Biotechnology Companies, Diagnostic Laboratories and others) - Industry Trends and Forecast to 2030.
Oligonucleotide Synthesis Market Analysis and Size
The growing usage of synthesized oligos in molecular diagnostics and clinical applications, the cumulative government funds and research and development expenses in pharmaceutical and biotechnology companies, and the increase in venture capital savings are the major factors expected to boost the growth of the oligonucleotide synthesis market in the forecast period. However, the cost erosion of synthesized oligos and the absence of a unified set of guidelines for therapeutic oligos are the reasons anticipated to most likely impede the growth of the oligonucleotide synthesis market during the forecast period. The advancing countries markets are to extend profitable opportunities. Despite that, the large-scale synthesis of oligos and the distribution of oligonucleotide drugs to particular targets will further challenge the growth of the oligonucleotide synthesis market in the coming years.
Data Bridge Market Research analyzes that the global oligonucleotide synthesis market which was USD 7.70 billion in 2022, would rocket up to USD 16.36 billion by 2030, and is expected to undergo a CAGR of 11.8% during the forecast period 2023 to 2030. This indicates the market value. “oligonucleotide” is expected to dominate the product segment of the global oligonucleotide synthesis market owing to the surge in government funding. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Oligonucleotide Synthesis Market Scope and Segmentation
Report Metric |
Details |
Forecast Period |
2023 to 2030 |
Base Year |
2022 |
Historic Year |
2021 (Customizable to 2015-2020) |
Quantitative Units |
Revenue in USD Million, Volumes in Units, Pricing in USD |
Segments Covered |
Product (Oligonucleotide, Reagents, and Equipment), Type (Custom Oligos and Predesigned Oligos), Application (Therapeutic Applications, Diagnostics, Research, and Others), End User (Academic Research Institutes, Pharmaceutical and Biotechnology Companies, Diagnostic Laboratories, and others) |
Countries Covered |
U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa |
Market Players Covered |
Agilent Technologies, Inc. (U.S.), Atdbio Ltd.(U.K.), LGC Limited (U.K.), Bio-Synthesis Inc.(U.S.), Eurofins Genomics (India), Kaneka Eurogentec S.A.(Belgium), General Electric (U.S.), Genscript (U.S.), AJINOMOTO CO., INC (Genedesign, Inc.) (Tokyo), Danaher (U.S.), Merck Kgaa (Germany) |
Market Opportunities |
|
Market Definition
Oligonucleotides are little remains of nucleic acids that are formed through enzymatic chemistry and genetic engineering. Oligonucleotides are mainly utilized in research laboratories for diagnostics, academic and industrial, and therapeutic functions. Oligonucleotide synthesis happens either commercially to provide facilities for several end-users or separately through DNA synthesizers for self-utilization. Presently, successive improvements in oligonucleotide synthesis, amplification, and computerization have entirely transformed biological research. It is also possible to do the customizations and get the necessary cycle online easily and at the necessary time. These essential services vary significantly by the expense of per base pair, error rates, lengths, and throughput, among others.
Global Oligonucleotide Synthesis Market Dynamics
Drivers
Government Initiatives for Raising Funds
There are growing government initiatives for raising funds to develop various genome projects to develop advanced therapeutics to treat multiple chronic and rare diseases. This is expected to increase the demand for oligonucleotides for drug development, boosting market growth.
Increased Demand for Covid-19 Diagnostics
The increased demand for COVID-19 diagnostics has, in turn, increased the global demand for oligonucleotide raw materials that form the basis of molecular diagnostic products.
Opportunities
Increasing Adoption of Oligonucleotides in Molecular Diagnostics
The increasing adoption of oligonucleotides in molecular diagnostics and clinical applications contributes to market growth.
Restraints/Challenges
Cost erosion of synthesized oligos:
the cost erosion of synthesized oligos and the absence of a unified set of guidelines for therapeutic oligos are the reasons anticipated to most likely impede the growth of the oligonucleotide synthesis market during the forecast period.
Recent Development
- In September 2021, SpeeDx invested in local oligonucleotide manufacturing to reduce supply chain risk and develop a more vital sovereign capacity for critical diagnostics. Such developments are expected to increase the adoption of oligonucleotides in drug development which is anticipated to fuel the market growth over the forecast period.
Global Oligonucleotide Synthesis Market Scope
The global oligonucleotide synthesis market is segmented on the basis of product, type, application, and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Synthesized Oligonucleotide
- Reagents And Equipment
Type
- Custom Oligos
- Predesigned Oligos
Application
- Therapeutic Applications,
- Diagnostics,
- Research
- Others
End\-User
- Academic Research Institutes
- Pharmaceutical And Biotechnology Companies
- Diagnostic Laboratories
- Others
Global Oligonucleotide Synthesis Market Regional Analysis/Insights
The global oligonucleotide synthesis market is analyzed and market size insights and trends are provided by country, product, type, application, and end-user as referenced above.
The countries covered in the global oligonucleotide synthesis market report are the U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa.
North America is expected to dominate the global oligonucleotide synthesis market because of the strong base of healthcare facilities, the strong presence of major players in the market, increasing cases of viral diseases, and rising number of research activities in this region.
Asia-Pacific is expected to witness significant growth during the forecast period of 2023 to 2030 due to the increase in government initiatives to promote awareness, growing research activities in the region, availability of massive untapped markets, a large population pool, and the growing demand for quality healthcare in the region.
The country section of the report also provides individual market-impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points like downstream and upstream value chain analysis, technical trends, Porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The global oligonucleotide synthesis market also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the global oligonucleotide synthesis market, the impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the global oligonucleotide synthesis market. The data is available for the historic period 2015-2020.
Competitive Landscape and Global Oligonucleotide Synthesis Market Share Analysis
The global oligonucleotide synthesis market competitive landscape provides details of competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus related to the market.
Some of the major players operating in the global oligonucleotide synthesis market are:
- Agilent Technologies, Inc. (U.S.)
- Atdbio Ltd.(U.K.)
- LGC Limited (U.K.)
- Bio-Synthesis Inc.(U.S.)
- Eurofins Genomics (India),
- Kaneka Eurogentec S.A.(Belgium)
- General Electric (U.S.)
- Genscript (U.S.)
- AJINOMOTO CO.,INC (Genedesign, Inc.) (Tokyo)
- Danaher (U.S.)
- Merck Kgaa (Germany)
SKU-